Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery
Ben Dowsing, British Heart Foundation Clinical Research Fellow at UCL, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Heart Journal, adding:
“Delighted to have presented HER-SAFE as a late breaking clinical trial at ESC 2026.
A first in population randomised controlled trial of heart failure therapy withdrawal in breast cancer survivors with recovered anti-HER2 cardiotoxicity.
HFT withdrawal appears feasible in most, with stable CMR derived cardiac function over 12 months.
Importantly this is first prospective, randomised evidence to guide shared decision making in this growing but often overlooked population.
HFT withdrawal may be an option for most, provided close surveillance is in place and the low risk of reversible, asymptomatic relapse is apparent.
A huge thank you to the participants, BHF and study team without whom this first of its kind work would not have been feasible.
Read the full manuscript in the European Heart Journal.”
Title: Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial
Authors: B Dowsing, H-M Dehbi, M S Andres, R Chung, A Oashou, J M Wilson, I Hussein, B Meredith, I Pierce, S Ahmed, J Pedra, O Worn, M Howe, S Assadullah, P Schmid, R Roylance, T Crake, M Westwood, A K Ghosh, D Auger, C M Plymen, J Baksi, M S Nazir, J C Moon, D Chen, A R Lyon, J M Walker, C H Manisty
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question